AICURIS.COM: Keyword Density Checker

Total words: 1598 | 2-word phrases: 428 | 3-word phrases: 453 | 4-word phrases: 458

PAGE INFO

Title	Try to keep the title under 60 characters (69 characters) AiCuris Anti-infective Cures AG - Clear Focus on Anti-Infective Cures
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (37 characters) Delivering Novel Anti-Viral Therapies

#	Keyword	Frequency	Density
1	read more	6	1.40%
2	for immunocompromised	3	0.70%
3	in a	3	0.70%
4	solutions for	3	0.70%
5	immunocompromised patients	3	0.70%
6	patients with	3	0.70%
7	and the	3	0.70%
8	immunocompromised people	2	0.47%
9	antiviral solutions	2	0.47%
10	population of	2	0.47%
11	transplant recipients	2	0.47%
12	pipeline of	2	0.47%
13	phase 3	2	0.47%
14	3 candidate	2	0.47%
15	at the	2	0.47%
16	candidate pritelivir	2	0.47%
17	and growing	2	0.47%
18	immune systems	2	0.47%
19	weakened immune	2	0.47%
20	to address	2	0.47%

#	Keyword	Frequency	Density
1	cynthia wat a	2	0.44%
2	solutions for immunocompromised	2	0.44%
3	phase 3 candidate	2	0.44%
4	3 candidate pritelivir	2	0.44%
5	weakened immune systems	2	0.44%
6	antiviral solutions for	2	0.44%
7	with our development	1	0.22%
8	research with our	1	0.22%
9	antiviral research with	1	0.22%
10	german antiviral research	1	0.22%
11	exceptional german antiviral	1	0.22%
12	opportunity to combine	1	0.22%
13	the opportunity to	1	0.22%
14	with the opportunity	1	0.22%
15	by cekom gmbh	1	0.22%
16	us with the	1	0.22%
17	capabilities and clinical	1	0.22%
18	cooperation provides us	1	0.22%
19	the cooperation provides	1	0.22%
20	license option agreement“	1	0.22%
21	and license option	1	0.22%
22	collaboration and license	1	0.22%
23	research dzif sign	1	0.22%
24	infection research dzif	1	0.22%
25	for infection research	1	0.22%
26	provides us with	1	0.22%
27	clinical expertise to	1	0.22%
28	and clinical expertise	1	0.22%
29	payment from licensing	1	0.22%
30	european approval for	1	0.22%

#	Keyword	Frequency	Density
1	phase 3 candidate pritelivir	2	0.44%
2	antiviral solutions for immunocompromised	2	0.44%
3	realized by cekom gmbh	1	0.22%
4	the cooperation provides us	1	0.22%
5	and license option agreement“	1	0.22%
6	collaboration and license option	1	0.22%
7	infection research dzif sign	1	0.22%
8	for infection research dzif	1	0.22%
9	center for infection research	1	0.22%
10	german center for infection	1	0.22%
11	the german center for	1	0.22%
12	and the german center	1	0.22%
13	provides us with the	1	0.22%
14	„aicuris and the german	1	0.22%
15	the respective poster sessions	1	0.22%
16	at the respective poster	1	0.22%
17	data at the respective	1	0.22%
18	aic468 data at the	1	0.22%
19	impressive aic468 data at	1	0.22%
20	with lively discussions around	1	0.22%
21	cooperation provides us with	1	0.22%
22	us with the opportunity	1	0.22%
23	in philadelphia with lively	1	0.22%
24	to develop novel therapies	1	0.22%
25	milestone payment from licensing	1	0.22%
26	euros milestone payment from	1	0.22%
27	million euros milestone payment	1	0.22%
28	15 million euros milestone	1	0.22%
29	received 15 million euros	1	0.22%
30	aicuris received 15 million	1	0.22%
31	develop novel therapies for	1	0.22%
32	expertise to develop novel	1	0.22%
33	with the opportunity to	1	0.22%
34	clinical expertise to develop	1	0.22%
35	and clinical expertise to	1	0.22%
36	capabilities and clinical expertise	1	0.22%
37	research with our development	1	0.22%
38	antiviral research with our	1	0.22%
39	german antiviral research with	1	0.22%
40	exceptional german antiviral research	1	0.22%

#	URL	Whois	Check
1	https://www.linkedin.com/company/aicuris-gmbh-&-co--kg	Whois	linkedin.com
2	https://www.cekom.de/36/	Whois	cekom.de